182 related articles for article (PubMed ID: 11156953)
1. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo.
Tohka S; Laukkanen M; Jalkanen S; Salmi M
FASEB J; 2001 Feb; 15(2):373-82. PubMed ID: 11156953
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).
Koskinen K; Vainio PJ; Smith DJ; Pihlavisto M; Ylä-Herttuala S; Jalkanen S; Salmi M
Blood; 2004 May; 103(9):3388-95. PubMed ID: 14726375
[TBL] [Abstract][Full Text] [Related]
3. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear.
Salmi M; Tohka S; Jalkanen S
Circ Res; 2000 Jun; 86(12):1245-51. PubMed ID: 10864915
[TBL] [Abstract][Full Text] [Related]
4. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding.
Jalkanen S; Karikoski M; Mercier N; Koskinen K; Henttinen T; Elima K; Salmivirta K; Salmi M
Blood; 2007 Sep; 110(6):1864-70. PubMed ID: 17548577
[TBL] [Abstract][Full Text] [Related]
5. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo.
Stolen CM; Marttila-Ichihara F; Koskinen K; Yegutkin GG; Turja R; Bono P; Skurnik M; Hänninen A; Jalkanen S; Salmi M
Immunity; 2005 Jan; 22(1):105-15. PubMed ID: 15664163
[TBL] [Abstract][Full Text] [Related]
6. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
[TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
Lalor PF; Edwards S; McNab G; Salmi M; Jalkanen S; Adams DH
J Immunol; 2002 Jul; 169(2):983-92. PubMed ID: 12097405
[TBL] [Abstract][Full Text] [Related]
8. A cell surface amine oxidase directly controls lymphocyte migration.
Salmi M; Yegutkin GG; Lehvonen R; Koskinen K; Salminen T; Jalkanen S
Immunity; 2001 Mar; 14(3):265-76. PubMed ID: 11290336
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).
Arvilommi AM; Salmi M; Kalimo K; Jalkanen S
Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974
[TBL] [Abstract][Full Text] [Related]
10. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule.
Smith DJ; Salmi M; Bono P; Hellman J; Leu T; Jalkanen S
J Exp Med; 1998 Jul; 188(1):17-27. PubMed ID: 9653080
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic control of leukocyte trafficking: role of VAP-1.
Salmi M; Jalkane S
Adv Exp Med Biol; 2002; 512():57-63. PubMed ID: 12405188
[No Abstract] [Full Text] [Related]
12. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes.
Salmi M; Tohka S; Berg EL; Butcher EC; Jalkanen S
J Exp Med; 1997 Aug; 186(4):589-600. PubMed ID: 9254657
[TBL] [Abstract][Full Text] [Related]
13. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse.
Merinen M; Irjala H; Salmi M; Jaakkola I; Hänninen A; Jalkanen S
Am J Pathol; 2005 Mar; 166(3):793-800. PubMed ID: 15743791
[TBL] [Abstract][Full Text] [Related]
14. VAP-1: an adhesin and an enzyme.
Salmi M; Jalkanen S
Trends Immunol; 2001 Apr; 22(4):211-6. PubMed ID: 11274927
[TBL] [Abstract][Full Text] [Related]
15. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans.
Jaakkola K; Jalkanen S; Kaunismäki K; Vänttinen E; Saukko P; Alanen K; Kallajoki M; Voipio-Pulkki LM; Salmi M
J Am Coll Cardiol; 2000 Jul; 36(1):122-9. PubMed ID: 10898423
[TBL] [Abstract][Full Text] [Related]
16. Induction and function of vascular adhesion protein-1 at sites of inflammation.
Salmi M; Kalimo K; Jalkanen S
J Exp Med; 1993 Dec; 178(6):2255-60. PubMed ID: 8245796
[TBL] [Abstract][Full Text] [Related]
17. Human vascular adhesion protein-1 in smooth muscle cells.
Jaakkola K; Kaunismäki K; Tohka S; Yegutkin G; Vänttinen E; Havia T; Pelliniemi LJ; Virolainen M; Jalkanen S; Salmi M
Am J Pathol; 1999 Dec; 155(6):1953-65. PubMed ID: 10595925
[TBL] [Abstract][Full Text] [Related]
18. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
19. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation.
Jalkanen S; Salmi M
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):18-26. PubMed ID: 17962625
[TBL] [Abstract][Full Text] [Related]
20. Endothelial amine oxidase AOC3 transiently contributes to adaptive immune responses in the airways.
Dunkel J; Aguilar-Pimentel JA; Ollert M; Fuchs H; Gailus-Durner V; de Angelis MH; Jalkanen S; Salmi M; Veres TZ
Eur J Immunol; 2014 Nov; 44(11):3232-9. PubMed ID: 25116373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
